Cannabis Policy Under the Obama Administration

What Obama inherited: the Bush-era context

When Barack Obama took office in January 2009, cannabis remained a Schedule I controlled substance under the 1961 Single Convention on Narcotic Drugs and the 1970 Controlled Substances Act. Thirteen states had enacted medical cannabis laws since California's Proposition 215 in 1996, but the Bush administration had treated state-legal medical operators as ordinary drug traffickers, conducting high-profile raids on California dispensaries ^[1].

Obama had a documented history of cannabis use as a teenager in Hawaii, which he recounted in his 1995 memoir Dreams from My Father ^[2]. As a presidential candidate in 2008, he stated that the federal government would not use Justice Department resources to circumvent state medical cannabis laws ^[3]. This campaign promise became the basis for the executive policy shifts that followed during his presidency.

The Ogden Memo (October 2009)

On October 19, 2009, Deputy Attorney General David Ogden issued a memorandum to U.S. Attorneys titled 'Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana' ^[4] Strong evidence. The memo instructed federal prosecutors that pursuing individuals 'whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana' was 'unlikely to be an efficient use of federal resources.'

The Ogden Memo is commonly remembered as a blanket de facto legalization of state medical programs. That characterization misses critical qualifications. The memo explicitly preserved federal authority to prosecute large-scale commercial cultivation, sales to minors, money laundering, and diversion across state lines. In practice, U.S. Attorneys in California, Montana, and Washington continued to prosecute dispensary operators under these exceptions, though the frequency and intensity of enforcement varied by jurisdiction. The memo created prosecutorial discretion but not legal immunity ^[4].

The Cole Memos (2011–2014) and banking guidance

Deputy Attorney General James M. Cole issued two major memoranda that clarified and expanded the Ogden framework. On June 29, 2011, Cole I memo clarified that the Ogden Memo did not protect large-scale commercial cultivation operations, even when state-licensed, and reinforced the limits on prosecutorial discretion ^[5] Strong evidence.

The pivotal document came after Colorado and Washington voters legalized adult-use cannabis in November 2012. On August 29, 2013, Cole issued the memo most commonly called 'the Cole Memo' ^[6] Strong evidence. It outlined eight federal enforcement priorities: preventing distribution to minors, preventing revenue flowing to cartels or organized crime, preventing diversion to non-legal states, preventing firearms and violence, preventing drugged driving, preventing cultivation on public lands, preventing possession on federal property, and preventing state-legal cover for large-scale trafficking. The memo stated that so long as states maintained 'strong and effective regulatory and enforcement systems' addressing these priorities, the DOJ would generally defer to state authority rather than prosecute ^[6].

On February 14, 2014, Cole and the Financial Crimes Enforcement Network (FinCEN) issued parallel guidance allowing banks to serve state-compliant cannabis businesses if they filed specific Suspicious Activity Reports (SARs) ^[7] Strong evidence. This created the legal framework that most state-licensed cannabis businesses still operate within. Banking access remained severely limited in practice—most state-legal operators still faced rejection by mainstream financial institutions—but the guidance provided a regulatory pathway ^[7].

Congressional action: the Rohrabacher–Farr amendment

The Obama administration did not introduce legislative reform, but Congress acted independently. In December 2014, the Rohrabacher–Farr amendment passed as part of the omnibus appropriations bill, prohibiting the Department of Justice from spending appropriated funds to interfere with state medical cannabis programs ^[8] Strong evidence. The Ninth Circuit Court of Appeals later confirmed in United States v. McIntosh (2016) that the amendment legally barred DOJ prosecutors from pursuing individuals operating in compliance with state medical laws ^[9] Strong evidence. Obama signed the annual appropriations bills containing the amendment but did not publicly advocate for it or claim ownership of the provision.

What did not change: rescheduling, arrests, and executive limits

Several widely repeated claims about Obama-era policy are either overstated or factually incorrect:

Rescheduling. Cannabis remained a Schedule I controlled substance throughout the Obama administration. The DEA denied rescheduling petitions in 2011 and again in August 2016, with DEA administrator Chuck Rosenberg citing the FDA's position that cannabis had no currently accepted medical use Strong evidence. No executive action or DOJ memo could change cannabis's scheduling; only Congress or the DEA (through a formal rulemaking process) could do so.

Federal arrests dropped dramatically. Federal cannabis prosecutions did decline during the Obama years, but this is often confused with overall arrest trends. State and local cannabis arrests remained high—the FBI's Uniform Crime Reports show approximately 600,000–700,000 cannabis arrests per year throughout most of Obama's term, the vast majority for simple possession ^[10] Strong evidence. These were prosecuted by state and local authorities under state law, not the federal system.

Obama personally championed legalization. He did not. In a January 2014 New Yorker interview, Obama called cannabis 'not very different from cigarettes' and said it was 'less dangerous than alcohol,' but he consistently said legalization was a question for Congress and the states to decide, not an executive priority ^[11].

The Cole Memo was law. It was internal DOJ policy guidance, not a statutory law or binding regulation. Attorney General Jeff Sessions rescinded the Cole Memo on January 4, 2018, after President Trump took office ^[12]. State cannabis markets continued to operate afterward, but this reflected political reality and state-level legal protections (like Rohrabacher–Farr and state constitutions), not federal legal protection.

Legacy and what changed by 2017

By the end of Obama's presidency in January 2017, significant structural changes had occurred in the cannabis landscape. Eight states plus the District of Columbia had legalized adult-use cannabis, 29 states had enacted medical programs, and an ancillary industry—testing laboratories, licensed retail operations, security firms, cultivation consultants—existed that had not existed in 2009. None of this expansion required a single change to the Controlled Substances Act, a congressional statute, or executive rescheduling. It occurred within the existing federal prohibition by means of prosecutorial discretion memos that could be, and were, reversed by subsequent administrations.

The policy shift was fundamentally about non-enforcement rather than reform. Obama-era guidance created breathing room for state experimentation but maintained the fiction of federal supremacy. Whether this constituted leadership on drug policy or simply calculated political avoidance remains contested. The historical record supports examining the question without mythology: it was neither the bold federal endorsement some legalization advocates wished for, nor the complete abandonment of federal authority that critics claimed.

Sources

How this page was made

Related

• 1961 Single Convention on Narcotic Drugs — The UN treaty that unified international drug control and shaped cannabis prohibition glob...
• Colorado Amendment 20 (2000) — Colorado's 2000 constitutional amendment creating medical cannabis protections and the fou...